Washington University in St. Louis (WU)
The focus of my research is immunotherapy for multiple myeloma. We are developing new CAR-T constructs targeting FCRL5, a protein expressed on most myeloma cells with the goal to test a lead candidate in clinical trials. I am also interested in iNKT cells for use as immunotherapy and am working to understand the biology (phenotype and function) of iNKT subsets.